Sirt2 inhibition suppressed the fibrogenic gene α-SMA and Fibronectin expression in TGF-β1 treated lung fibroblasts and primary lung fibroblasts derived from patients with IPF. Here, SIRT2 is linked to idiopathic pulmonary fibrosis.